New Stock News | Gao Guang Pharmaceuticals has once again submitted an application to the Hong Kong Stock Exchange. It has been in a state of continuous loss during the reporting period.

According to the Securities Times app, it was disclosed by the Hong Kong Stock Exchange on June 8 that Hangzhou Gaoguang Pharmaceutical Co., Ltd. (referred to as Gaoguang Pharmaceutical) submitted an application to the Main Board of the Hong Kong Stock Exchange, with China International Capital Corporation and CMB International as its joint sponsors. The company had previously submitted an IPO application to the Hong Kong Stock Exchange on December 4, 2025.